LANSING, MI–October 1, 2010- Kraig Biocraft Laboratories, Inc. (KBLB) announces today that Kim Thompson cordially invites all current, new and prospective shareholders to participate in the Company’s conference call to be held on Friday, October 8, 2010 at 4:30 p.m. EDT.
Thompson, the Company’s CEO and Founder, will review the recent development of recombinant spider silk, the Company’s intellectual property and commercialization rights to this powerful technology, as well as what is in the pipeline for near term research and development payoff, followed by a question and answer period.
The conference call phone number and other details will be announced in a follow-up company release early next week. Shareholders are invited to submit questions to firstname.lastname@example.org prior to the event.
For more information on Kraig Biocraft Laboratories please visit the Company’s web site: https://kraiglabs.com.
Statements in this press release about the company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “hopes,” “develops,” “researching,” “research,” “potential,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.